Ravelcare Stock Performance Analyzed

Ravelcare, a digital beauty brand, started trading on the BSE (a stock market) with a significant premium. The stock price reached Rs 201, representing a 54.62% increase compared to its initial offering price of Rs 130. This shows strong investor confidence in the company’s growth potential. The stock is currently limited to a 5% increase above this initial price.

Key Points

• Ravelcare traded at a 54.62% premium, significantly above the IPO price.
• The stock’s high of Rs 208.95 indicates positive market sentiment.
• 7.46 lakh shares changed hands, reflecting high trading activity.
• The IPO was heavily subscribed, 406.72 times, demonstrating strong demand.
• Funds raised from anchor investors aided expansion plans and brand building.
• Revenue reached Rs 14.39 crore, signaling promising financial growth.

The initial public offering (IPO) for Ravelcare was very successful, with investors paying a high price for the shares. This happened because Ravelcare is a new company focused on beauty and personal care products, selling directly to customers online. They’ve quickly grown into international markets, including the UAE, Australia, and the USA.

To raise money for this growth, Ravelcare received an additional investment of Rs 6.82 crore from investors before the stock even started trading. This money is being used to build a new factory, improve how they advertise their products, and generally make the company stronger.

Ravelcare’s business model focuses on creating and selling products directly to consumers through online channels, supported by popular online platforms. They are also planning to create their own factory to control production and improve quality.

As of September 30, 2025, the company employs approximately 20 people. Their financial performance for the period ending September 30, 2025, showed strong revenue (Rs 14.39 crore) and profit after tax (Rs 3.19 crore), showcasing solid growth.

Strong initial investor interest and financial performance suggest Ravelcare is a promising investment opportunity.